Jasper Therapeutics, Inc. — S-8 Filings
6 S-8 filings on record
This page lists all S-8 filings submitted to the SEC by Jasper Therapeutics, Inc. (JSPRW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Jasper Therapeutics, Inc. has filed 6 S-8 documents with the SEC since 2019. To view all SEC filings by Jasper Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | REGISTRATION STATEMENT | 0001213900-24-050751 | Jun 7, 2024 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-24-020154 | Mar 5, 2024 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-23-066283 | Aug 11, 2023 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-23-018584 | Mar 8, 2023 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-22-014221 | Mar 22, 2022 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-22-013605 | Mar 18, 2022 | — |